2022 Q4 Form 10-Q Financial Statement

#000121390022071138 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $2.000K $87.00K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.896M $2.740M $5.088M
YoY Change -32.46% -46.15% 81.71%
% of Gross Profit
Research & Development $4.575M $4.503M $6.391M
YoY Change -30.06% -29.54% 3.08%
% of Gross Profit
Depreciation & Amortization $97.00K $100.0K $337.0K
YoY Change -70.34% -70.33% -3.71%
% of Gross Profit
Operating Expenses $4.575M $4.503M $11.44M
YoY Change -57.62% -60.64% 30.9%
Operating Profit -$6.679M -$6.923M -$11.44M
YoY Change -38.13% -39.49%
Interest Expense -$212.0K -$194.0K $9.000K
YoY Change 46.21% -2255.56% -96.4%
% of Operating Profit
Other Income/Expense, Net -$1.363M $848.0K
YoY Change
Pretax Income -$8.254M -$6.269M -$11.43M
YoY Change -24.55% -45.16% 34.65%
Income Tax
% Of Pretax Income
Net Earnings -$8.117M -$6.121M -$11.43M
YoY Change -25.8% -46.46% 34.65%
Net Earnings / Revenue -405850.0% -7035.63%
Basic Earnings Per Share -$0.24 -$0.19 -$0.36
Diluted Earnings Per Share -$0.24 -$0.19 -$357.2K
COMMON SHARES
Basic Shares Outstanding 32.66M shares 32.62M shares 32.00M shares
Diluted Shares Outstanding 33.19M shares 32.56M shares 32.00M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.25M $48.02M $60.67M
YoY Change -18.8% -20.86% 50.03%
Cash & Equivalents $8.818M $8.744M $14.61M
Short-Term Investments $38.43M $39.27M $46.06M
Other Short-Term Assets $2.894M $1.708M $2.155M
YoY Change 46.9% -20.74% -4.22%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.14M $49.72M $62.83M
YoY Change -16.65% -20.86% 47.17%
LONG-TERM ASSETS
Property, Plant & Equipment $673.0K $707.0K $1.749M
YoY Change -92.79% -59.58% -49.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $18.48M
YoY Change 52.37%
Other Assets $97.00K $5.000K $689.0K
YoY Change -86.8% -99.27% 1.32%
Total Long-Term Assets $9.787M $10.03M $20.92M
YoY Change -53.46% -52.05% 28.67%
TOTAL ASSETS
Total Short-Term Assets $50.14M $49.72M $62.83M
Total Long-Term Assets $9.787M $10.03M $20.92M
Total Assets $59.93M $59.75M $83.75M
YoY Change -26.18% -28.65% 42.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.257M $1.329M $3.723M
YoY Change -69.02% -64.3% 106.83%
Accrued Expenses $1.507M $995.0K $6.642M
YoY Change -72.78% -85.02% 45.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.284M $5.018M $10.37M
YoY Change -44.93% -51.59% 24.13%
LONG-TERM LIABILITIES
Long-Term Debt $22.68M $20.72M $23.44M
YoY Change -2.09% -11.61%
Other Long-Term Liabilities $7.002M $7.113M $1.031M
YoY Change -18.5% 589.91% -37.89%
Total Long-Term Liabilities $29.68M $27.84M $24.48M
YoY Change -6.53% 13.73% 1374.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.284M $5.018M $10.37M
Total Long-Term Liabilities $29.68M $27.84M $24.48M
Total Liabilities $34.96M $32.85M $34.84M
YoY Change -15.44% -5.7% 248.4%
SHAREHOLDERS EQUITY
Retained Earnings -$385.5M -$377.4M
YoY Change
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.19M $24.19M $48.91M
YoY Change
Total Liabilities & Shareholders Equity $59.93M $59.75M $83.75M
YoY Change -26.18% -28.65% 42.06%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$8.117M -$6.121M -$11.43M
YoY Change -25.8% -46.46% 34.65%
Depreciation, Depletion And Amortization $97.00K $100.0K $337.0K
YoY Change -70.34% -70.33% -3.71%
Cash From Operating Activities -$6.280M -$7.609M -$8.789M
YoY Change -36.33% -13.43% 43.14%
INVESTING ACTIVITIES
Capital Expenditures $68.00K $73.00K -$15.00K
YoY Change -334.48% -586.67% -118.75%
Acquisitions
YoY Change
Other Investing Activities $737.0K $6.466M -$7.225M
YoY Change -94.86% -189.49% -268.81%
Cash From Investing Activities $669.0K $6.393M -$7.240M
YoY Change -95.33% -188.3% -272.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.693M
YoY Change
NET CHANGE
Cash From Operating Activities -6.280M -$7.609M -8.789M
Cash From Investing Activities 669.0K $6.393M -7.240M
Cash From Financing Activities 5.693M
Net Change In Cash 82.00K -$1.382M $0.00
YoY Change -98.16% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$6.280M -$7.609M -$8.789M
Capital Expenditures $68.00K $73.00K -$15.00K
Free Cash Flow -$6.348M -$7.682M -$8.774M
YoY Change -35.45% -12.45% 41.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
usd
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
001-31392
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
PLURI INC.
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0351734
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
MATAM Advanced Technology Park
CY2022Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Building No. 5
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Haifa
CY2022Q3 dei Entity Address Country
EntityAddressCountry
IL
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
3508409
CY2022Q3 dei Security12b Title
Security12bTitle
Common Shares, par value $0.00001
CY2022Q3 dei Trading Symbol
TradingSymbol
PLUR
CY2022Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32657244 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8744000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9772000 usd
CY2022Q3 plur Shortterm Bank Deposits
ShorttermBankDeposits
39271000 usd
CY2022Q2 plur Shortterm Bank Deposits
ShorttermBankDeposits
45244000 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
653000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
1007000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1055000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1724000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
49723000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
57747000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
634000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
634000 usd
CY2022Q3 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
611000 usd
CY2022Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
661000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
707000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
739000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8074000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8270000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14000 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
10031000 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
10318000 usd
CY2022Q3 us-gaap Assets
Assets
59754000 usd
CY2022Q2 us-gaap Assets
Assets
68065000 usd
CY2022Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1329000 usd
CY2022Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1785000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
995000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1630000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
611000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
619000 usd
CY2022Q3 plur Accrued Vacations Current
AccruedVacationsCurrent
791000 usd
CY2022Q2 plur Accrued Vacations Current
AccruedVacationsCurrent
1053000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1292000 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1742000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5018000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6829000 usd
CY2022Q3 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
811000 usd
CY2022Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
867000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6302000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6505000 usd
CY2022Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
20722000 usd
CY2022Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
21678000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
27835000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29050000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32634662 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32634662 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32507491 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32507491 shares
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6269000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26901000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6269000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
401576000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
401302000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-377384000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-371263000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
24192000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
30039000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
2709000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
2147000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26901000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32186000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59754000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68065000 usd
CY2022Q3 us-gaap Revenues
Revenues
87000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4503000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6391000 usd
CY2022Q3 plur Government And Third Party Grants Received
GovernmentAndThirdPartyGrantsReceived
233000 usd
CY2021Q3 plur Government And Third Party Grants Received
GovernmentAndThirdPartyGrantsReceived
38000 usd
CY2022Q3 plur Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
4270000 usd
CY2021Q3 plur Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
6353000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2740000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5088000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6923000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11441000 usd
CY2022Q3 plur Financial Expenses
FinancialExpenses
194000 usd
CY2021Q3 plur Financial Expenses
FinancialExpenses
228000 usd
CY2022Q3 plur Financial Income
FinancialIncome
848000 usd
CY2021Q3 plur Financial Income
FinancialIncome
237000 usd
CY2022Q3 plur Financial Income Net
FinancialIncomeNet
654000 usd
CY2021Q3 plur Financial Income Net
FinancialIncomeNet
9000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-6269000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11432000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-148000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6121000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-11432000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32562596 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32000789 shares
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57151000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3188000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11432000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48907000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32186000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
984000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1382000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11432000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
100000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
337000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
984000 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3188000 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-674000 usd
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-277000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-450000 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-222000 usd
CY2022Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1344000 usd
CY2021Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-696000 usd
CY2022Q3 plur Decrease In Operating Lease Right Of Use Asset And Liability
DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability
15000 usd
CY2021Q3 plur Decrease In Operating Lease Right Of Use Asset And Liability
DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability
84000 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
493000 usd
CY2021Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
340000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
166000 usd
CY2021Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
591000 usd
CY2022Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-957000 usd
CY2021Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-406000 usd
CY2022Q3 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-5000 usd
CY2021Q3 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-2000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7609000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8789000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
73000 usd
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 usd
CY2022Q3 plur Proceeds From Withdrawal Of Shortterm Deposits
ProceedsFromWithdrawalOfShorttermDeposits
6466000 usd
CY2021Q3 plur Proceeds From Withdrawal Of Shortterm Deposits
ProceedsFromWithdrawalOfShorttermDeposits
-12084000 usd
CY2021Q3 plur Proceeds From Withdrawal Of Longterm Deposits
ProceedsFromWithdrawalOfLongtermDeposits
4859000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6393000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7240000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-166000 usd
CY2021Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-591000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16620000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11413000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31838000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10031000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15218000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8744000 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
14611000 usd
CY2022Q3 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
653000 usd
CY2021Q3 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
607000 usd
CY2022Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
634000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10031000 usd
CY2022Q3 plur Deferred Interest Rate Percentage
DeferredInterestRatePercentage
0.04 pure
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15218000 usd
CY2022Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
187500 shares
CY2022Q1 plur Additional Investment
AdditionalInvestment
7500000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0325 pure
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70 pure
CY2022Q3 plur Compensation Expense Recognized During The Period
CompensationExpenseRecognizedDuringThePeriod
385000 usd
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-size: 10pt"><i>c.</i></span></td> <td style="font-size: 10pt"><span style="font-size: 10pt"><b><i>Use of estimates</i></b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -1.35pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -1.35pt"> </p>
CY2022Q3 plur Fixed Interest Rate
FixedInterestRate
0 pure
CY2022Q3 plur Cash And Deposits
CashAndDeposits
1287000 usd
CY2022Q3 plur Percentage Of Qualified Expenditures
PercentageOfQualifiedExpenditures
0.50 pure
CY2022Q3 plur Royalty Rate Sales
RoyaltyRateSales
0.03 pure
CY2022Q3 plur Royalty Rate Payable On Grants Received
RoyaltyRatePayableOnGrantsReceived
1 pure
CY2022Q3 plur Grants Received
GrantsReceived
27574000 usd
CY2020Q2 plur Subsidiary Loan
SubsidiaryLoan
50000000 eur
CY2020Q2 plur Contract Period
ContractPeriod
36 months
CY2022Q3 plur Contractual Interest Rate For Funds Borrowed
ContractualInterestRateForFundsBorrowed
0.04 pure
CY2021Q2 plur First Tranche Price
FirstTranchePrice
20000000 eur
CY2021Q2 plur Annual Interest Percentage
AnnualInterestPercentage
0.04 pure
CY2022Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
19677000 usd
CY2022Q3 plur Accrued Interest
AccruedInterest
1045000 usd
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001158780
CY2022Q3 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
11800000 usd
CY2022Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
12000 usd
CY2021Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
2000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2359000 usd
CY2022Q3 plur Compensation Expenses
CompensationExpenses
2000 usd
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
usd
CY2021Q3 us-gaap Revenues
Revenues
usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
usd
CY2022Q3 plur Noncontrolling Interest In Plurinuva Ltd
NoncontrollingInterestInPlurinuvaLtd
usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
plur-20220930_cal.xml Edgar Link unprocessable
plur-20220930_def.xml Edgar Link unprocessable
plur-20220930_lab.xml Edgar Link unprocessable
plur-20220930_pre.xml Edgar Link unprocessable
0001213900-22-071138-index-headers.html Edgar Link pending
0001213900-22-071138-index.html Edgar Link pending
0001213900-22-071138.txt Edgar Link pending
0001213900-22-071138-xbrl.zip Edgar Link pending
f10q0922ex31-1_pluriinc.htm Edgar Link pending
f10q0922ex31-2_pluriinc.htm Edgar Link pending
f10q0922ex32-1_pluriinc.htm Edgar Link pending
f10q0922ex32-2_pluriinc.htm Edgar Link pending
f10q0922_pluriinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
plur-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
f10q0922_pluriinc_htm.xml Edgar Link completed